Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3653109

CC1CCC[N+]1(c1ccc(NC(=O)c2cccnc2)cc1)C1CCNC1.O=C(O)C(F)(F)F

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.45
NPC1 O15118 4/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
MAPT P10636 3/20 0.45
GAA P10253 1/20 0.45
TP53 P04637 2/20 0.41
ALDH1A1 P00352 2/20 0.41
GFER P55789 2/20 0.41
ROCK2 O75116 1/20 0.41
ROCK1 Q13464 1/20 0.41
KMT2A Q03164 2/20 0.41
CYP3A4 P08684 1/20 0.41
NPSR1 Q6W5P4 1/20 0.40
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3653079 0.94 RAB9A (0.50) RAB9ANPC1SMN1; SMN2MAPTGAA
Trifluoroacetic Acid SCHEMBL3656228 0.89 RAB9A (0.46) RAB9ANPC1SMN1; SMN2MAPTGAA
SCHEMBL3655451 0.85 TSHR (0.40) SMN1; SMN2GAAALDH1A1GFERKMT2A
Trifluoroacetic Acid SCHEMBL3654963 0.85
Trifluoroacetic Acid SCHEMBL3659571 0.84 RAB9A (0.45) RAB9ANPC1SMN1; SMN2MAPTTP53
Trifluoroacetic Acid SCHEMBL3657679 0.84 RAB9A (0.46) RAB9ANPC1SMN1; SMN2MAPTGAA
Trifluoroacetic Acid SCHEMBL3657521 0.83 MEN1 (0.42) RAB9ANPC1SMN1; SMN2MAPTTP53
Trifluoroacetic Acid SCHEMBL3653624 0.83 KDM4E (0.40) MAPTTP53ALDH1A1
SCHEMBL3658339 0.82 RAB9A (0.52) RAB9ANPC1SMN1; SMN2MAPTGAA
Trifluoroacetic Acid SCHEMBL3654346 0.81 JAK3 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2212282-A1 SUBSTITUTED N-PHENYL-BIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF Sanofi-Aventis (FR) 2010-08-04 EP disclosed
WO-2009052065-A1 SUBSTITUTED N-PHENYL-BIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2009-04-23 WO disclosed